//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Always exciting to see new HF agents in development! I enjoyed reading this interesting study using porcine model of HF with some promising outcomes for MiR-132. Available now in @escardio.bsky.social journal EHJ-IMP: academic.oup.com/ehjimp/artic...
10mo
academic.oup.com
AbstractAims. Cardiac miR-132 has been proposed as a target for heart failure (HF) therapy. CDR132L, a rationally designed synthetic oligonucleotide inhibi
MiR-132 inhibition improves myocardial strain in a large animal model of chronic left ventricular adverse remodelling
Anna Kate Barton